Skip to Content

Join the 'Solid Tumors' group to help and get support from people like you.

Solid Tumors News

Many Cancer Survivors Struggle to Make Ends Meet

Posted 14 Mar 2016 by Drugs.com

MONDAY, March 14, 2016 – Many cancer survivors struggle with money problems that can affect their mental health and quality of life, a new study suggests. Researchers analyzed 2011 data from over 19 million U.S. cancer survivors to determine rates of financial troubles among these patients. At least 29 percent of the survivors reported at least one financial problem associated with their cancer, its treatment or lasting effects of treatment. Specifically, 21 percent said they worried about paying large medical bills, 11.5 percent could not pay the cost of medical care visits, 7.6 percent said they had to borrow money or go into debt, 1.5 percent declared bankruptcy, and 8.6 percent reported other money problems. Cancer survivors facing financial struggles were at higher risk for depression and mental distress, had lower physical and mental health-related quality of life, and were more ... Read more

Related support groups: Depression, Anxiety and Stress, Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Brain Tumor, Psychiatric Disorders, Melanoma, Cervical Cancer, Bladder Cancer, Stomach Cancer, Testicular Cancer, Solid Tumors, Urinary Tract Cancer

U.S. Cancer Death Rate Continues to Fall

Posted 9 Mar 2016 by Drugs.com

WEDNESDAY, March 9, 2016 – Overall rates of cancer and deaths from cancer in the United States continue to decline, a newly released report says. However, an increase in liver cancer deaths is cause for concern, the report authors noted. An increase in hepatitis C infections is likely a major reason for the increase, they said. "The latest data show many cancer prevention programs are working and saving lives," Dr. Tom Frieden, director of the U.S. Centers for Disease Control and Prevention, said in a news release from the organizations that issued the report. "But the growing burden of liver cancer is troublesome. We need to do more work promoting hepatitis testing, treatment, and vaccination," Frieden added. The Report to the Nation on the Status of Cancer is released each year by the American Cancer Society, the U.S. Centers for Disease Control and Prevention, the National Cancer ... Read more

Related support groups: Cancer, Hepatitis C, Smoking, Breast Cancer, Prostate Cancer, Smoking Cessation, Cirrhosis, Lung Cancer, Colorectal Cancer, Hepatitis B, Basal Cell Carcinoma, Brain Tumor, Liver Cirrhosis, Melanoma, Skin Cancer, Ovarian Cancer, Cervical Cancer, Bladder Cancer, Melanoma - Metastatic, Stomach Cancer

Majority of Americans and Canadians Expects Cancer Cure in Their Lifetime

Posted 4 Feb 2016 by Drugs.com

THURSDAY, Feb. 4, 2016 – A majority of American and Canadian adults believe a cure for cancer will be found in their lifetime, and that a cancer diagnosis is not a death sentence, according to a new Harris Poll. Nearly three out of five Americans and Canadians expect a cure for cancer in their lifetime. That belief is especially strong among those ages 18 to 34. Nearly three-quarters of young Americans and 69 percent of Canadians in that age group expect a cure in their lifetime. And, about two-thirds of Americans and Canadians don't think death is inevitable when someone is diagnosed with cancer, the poll found. However, Americans adults under 35 are more likely to believe that a cancer diagnosis is a death sentence than those 35 and older (39 percent vs. 29 percent). Americans whose lives have been affected by cancer are also more likely to view cancer as deadly compared to those who ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Brain Tumor, Melanoma, Skin Cancer, Pancreatic Cancer, Ovarian Cancer, Cervical Cancer, Stomach Cancer, Breast Cancer, Prevention, Head and Neck Cancer, Gastric Cancer, Testicular Cancer, Breast Cancer - Palliative, Solid Tumors, Urinary Tract Cancer

Terminal Cancer Patients in U.S. Less Likely to Die in Hospitals

Posted 19 Jan 2016 by Drugs.com

TUESDAY, Jan. 19, 2016 – Comparing end-of-life practices internationally, researchers found the United States has the lowest percentage of in-hospital cancer deaths among seven developed countries. Terminally ill U.S. cancer patients also spend less time in the hospital the last six months of life than those in the other countries, although they are more likely to receive intensive care and chemotherapy, researchers found. The study, published in the Jan. 19 issue of the Journal of the American Medical Association, suggests that end-of-life care has changed significantly in response to patient preferences. "In the early 1980s, more than 70 percent of U.S. cancer patients died in hospital," wrote Dr. Ezekiel Emanuel, of the University of Pennsylvania's Perelman School of Medicine, and colleagues. Over the last 30 years, the researchers said, several factors have helped advance ... Read more

Related support groups: Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Brain Tumor, Melanoma, Skin Cancer, Cervical Cancer, Bladder Cancer, Stomach Cancer, Solid Tumors, History - Skin Cancer, Urinary Tract Cancer

Targeted Drug Shows Promise Against Advanced Kidney Cancer

Posted 6 Jan 2016 by Drugs.com

WEDNESDAY, Jan. 6, 2016 – A targeted cancer drug appears to be effective against advanced kidney cancer, although its side effects may keep it from becoming widely used, researchers report. The drug, cabozantinib, proved more effective across-the-board in kidney cancer patients than another targeted drug called everolimus, said lead researcher Dr. Bernard Escudier. He is chair of the genitourinary oncology committee at the Institut Gustave Roussy in Villejuif, France. Overall, cabozantinib provided "almost a 50 percent improvement in progression-free survival" over everolimus, Escudier said. Cabozantinib works by interrupting several different cellular processes that help cancer grow and spread, Escudier explained. Unfortunately, that widespread approach also creates worrisome toxic side effects, he added. "Based on this multi-targeted action, we have quite a lot of side effects. ... Read more

Related support groups: Cancer, Renal Failure, Renal Cell Carcinoma, Chronic Kidney Disease, Solid Tumors, Cabozantinib, Urinary Tract Tumors, Urinary Tract Cancer, Cometriq

Media Often Overplays Cancer Drug Research, Study Finds

Posted 29 Oct 2015 by Drugs.com

THURSDAY, Oct. 29, 2015 – News articles that promise "breakthrough, "game-changing" new cancer drugs could irresponsibly raise the hopes of desperate patients, a new report suggests. Just five days' worth of news last June contained 94 articles that lavishly praised 36 different cancer drugs, researchers found by combing Google. Unfortunately, half of the "marvel" drugs had not been approved by the U.S. Food and Drug Administration, and 14 percent had never been tested on humans, the results showed. "The net effect is really confusion," said study co-author Dr. Vinay Prasad, an oncologist at Oregon Health and Science University. "We found that the use of superlatives or grandiose descriptors of drugs happens whether drugs are approved or not, whether they are tested in people or not, or whether they improve survival or not," Prasad said. "I think the average person who follows cancer ... Read more

Related support groups: Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Breast Cancer, Prevention, Solid Tumors

Young Cancer Survivors Often Develop New Malignancies

Posted 6 Oct 2015 by Drugs.com

TUESDAY, Oct. 6, 2015 – Teen and young adult cancer survivors are at increased risk for other cancers later in life, a new study reveals. Researchers analyzed U.S. National Cancer Institute data on people who survived cancers before age 40. They had the most common types of cancers in that age group: leukemia, lymphoma, testicular, ovarian, thyroid, breast, soft tissue and bone cancers. "This is a patient demographic that has been largely overlooked," said senior study author Dr. Robert Goldsby, a professor of pediatrics at the University of California, San Francisco Benioff Children's Hospital. Over 30 years, nearly 14 percent of the survivors were diagnosed with another, different type of cancer. On average, the second cancer occurred within 15 years. Compared to people in the general population, patients successfully treated for cancer between ages 15 and 39 were nearly 60 percent ... Read more

Related support groups: Cancer, Breast Cancer, Hairy Cell Leukemia, Chronic Myelogenous Leukemia (CML), Leukemia, Lymphoma, Basal Cell Carcinoma, Melanoma, Skin Cancer, Chronic Lymphocytic Leukemia (CLL), Ovarian Cancer, Non-Hodgkin's Lymphoma, Acute Myeloid Leukemia, Stomach Cancer, Cutaneous T-cell Lymphoma, Hodgkin's Lymphoma, Acute Lymphoblastic Leukemia, Soft Tissue Sarcoma, Acute Lymphocytic Leukemia, Testicular Cancer

As HIV Patients Live Longer, Certain Cancer Risks Rise: Study

Posted 5 Oct 2015 by Drugs.com

MONDAY, Oct. 5, 2015 – Antiretroviral therapy has extended the lives of people with HIV, but living longer may increase these patients' risk for certain cancers. A study of nearly 90,000 HIV patients revealed a rise in three types of cancer as the AIDS-causing virus has evolved from a probable death sentence into a manageable chronic condition. "We found that the risk of some cancers, such as anal, colorectal and liver cancers, are increasing over time mainly because HIV patients are living longer," said study lead author Michael Silverberg, of the Kaiser Permanente division of research in Oakland, Calif. Kaiser Permanente is one of the nation's largest health plans. According to the U.S. National Cancer Institute, HIV patients have always faced a significantly higher cancer risk, most notably for Kaposi sarcoma, non-Hodgkin lymphoma and cervical cancer. That's because of a generally ... Read more

Related support groups: Cancer, HIV Infection, Colorectal Cancer, Cervical Cancer, Solid Tumors

Better Imaging Scans Catching More Thyroid Cancers: Study

Posted 11 Sep 2015 by Drugs.com

FRIDAY, Sept. 11, 2015 – Advanced imaging technology has helped doctors spot more cases of thyroid cancer over the past decade, a new study finds. But the Mayo Clinic researchers warn that nearly one-third of these cases involve people with low-risk tumors. "We are spotting more cancers, but they are cancers that are not likely to cause harm," study author Dr. Juan Brito Campana, an assistant professor of medicine at the Mayo Clinic in Rochester, Minn., said in a Mayo news release. "Their treatment, however, is likely to cause harm, as most thyroid cancers are treated by surgically removing all or part of the thyroid gland. This is a risky procedure that can damage a patient's vocal cords or leave them with lifelong calcium deficiencies," he said. Treatment for thyroid cancer can also be a financial burden for patients and their families, Brito Campana added. In 2013 alone, the total ... Read more

Related support groups: Cancer, Thyroid Disease, Thyroid Cancer, Diagnosis and Investigation, Head and Neck Cancer, Thyroid Tumor, Body Imaging, Solid Tumors, Head Imaging

U.S. Oncologists Decry High Cost of Cancer Drugs

Posted 23 Jul 2015 by Drugs.com

THURSDAY, July 23, 2015 – Soaring costs for cancer drugs are hurting patient care in the United States, a group of top oncologists claim. "High cancer-drug prices are affecting the care of patients with cancer and our health care system," Dr. Ayalew Tefferi, a hematologist at Mayo Clinic in Rochester, Minn., said in a Mayo news release. Tefferi and his colleagues made a number of recommendations on how to address the problem in a commentary published July 23 in the Mayo Clinic Proceedings. Allowing Medicare to negotiate drug prices is one of the suggestions the team of 118 leading cancer experts offered as a possible solution. Along with their recommendations, the group also expressed support for a patient-based grassroots movement on change.org that is demanding action on the issue. "The average gross household income in the U.S. is about $52,000 per year. For an insured patient with ... Read more

Related support groups: Cancer, Provera, Depo-Provera, Methotrexate, Breast Cancer, Accutane, Lupron, Prostate Cancer, Tamoxifen, Medroxyprogesterone, Arimidex, Tretinoin, Femara, Fluorouracil, Lupron Depot, Gleevec, Lung Cancer, Rituxan, Colorectal Cancer, Renal Cell Carcinoma

'Wiser' Surgeries for Those With Terminal Cancers

Posted 11 May 2015 by Drugs.com

MONDAY, May 11, 2015 – While surgery rates for patients with late-stage, terminal cancers have stayed about the same in recent years, complications and deaths for these patients have fallen because surgeons are more selective about who has surgery, a new study finds. "Surgeons are becoming wiser," study author Dr. Sarah Bateni, a surgery resident at the University of California, Davis, said in a university news release. "Our research suggests that surgeons may be operating on healthier patients who are more likely to recover well from an operation," she said. "These are patients who can perform activities of daily living without assistance, for example." As Bateni explained, there are a number of reasons why surgeons might operate on late-stage cancer patients. "Some of it has to do with the patients and families," she said. "If the patient is uncomfortable, the family wants a ... Read more

Related support groups: Surgery, Cancer, Colorectal Cancer, Head & Neck Surgery, Neurosurgery, Surgical Prophylaxis, Gastrointestinal Surgery, Solid Tumors, Cardiothoracic Surgery, Biliary Tract Surgery

18 Million U.S. Cancer Survivors Expected by 2022: Report

Posted 14 Jun 2012 by Drugs.com

THURSDAY, June 14 – There are now more than 13 million cancer survivors living in the United States and that number is expected to reach 18 million in just 10 years, a new report predicts. This dramatic increase will be driven, in large part, by a combination of earlier diagnosis and better treatment of some of the most common cancers, according to the report from the American Cancer Society and the U.S. National Cancer Institute. "We are focusing on the number of people who are now alive who have experienced cancer at some time in the past, and their transition from treatment to recovery and the balance of their life," said report co-author Elizabeth Ward, national vice president of intramural research at the American Cancer Society. More people are surviving cancer because the number of people diagnosed with cancer is rising and because the size of this population, particularly older ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Brain Tumor, Skin Cancer, Cervical Cancer, Bladder Cancer, Head and Neck Cancer, Gastric Cancer, Solid Tumors

Ask a Question

Further Information

Related Condition Support Groups

Cancer

Related Drug Support Groups

methotrexate, Avastin, hydroxyurea, Hydrea, Taxotere, bevacizumab, docetaxel, Droxia, Methotrexate LPF Sodium, view more... Trexall, Idamycin, Mylocel, Idamycin PFS, idarubicin, Folex PFS